Related Experiment Video
Updated: Jan 9, 2026
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
The Coronary Microcirculation Re-explored: Pathophysiological Insights and Clinical Implications
Ahmed Elamin1, Mustafa Abdimalik2, Mohanad Abdelrahim1
1Department of Cardiology, Liverpool University Hospitals NHS Foundation Trust Liverpool, UK.
Insights
Coronary microvascular dysfunction (CMD) causes myocardial ischaemia, especially in patients without blocked arteries. Understanding CMD
Area of Science:
- Cardiology
- Vascular Biology
- Physiology
Background:
- Coronary microvascular dysfunction (CMD) is a key cause of myocardial ischaemia.
- It significantly affects patients without obstructive coronary artery disease.
Purpose of the Study:
- To review the anatomy and physiology of coronary microcirculation.
- To explore the role of endothelial dysfunction and endothelin-1 in CMD.
- To discuss diagnostic and therapeutic strategies for CMD.
Main Methods:
- Review of existing literature on coronary microcirculation.
- Emphasis on endothelial dysfunction and endothelin-1.
- Discussion of diagnostic tools like PET, cardiac MRI, and intracoronary testing.
Main Results:
- Endothelial dysfunction and endothelin-1 are central to CMD pathogenesis.
- Various invasive and non-invasive methods aid CMD diagnosis.
- Risk factor modification and pharmacotherapy are current management mainstays.
Conclusions:
- A thorough grasp of CMD is vital for accurate diagnosis.
- Developing effective treatments for ischaemic symptoms without coronary obstruction is crucial.
- Targeting endothelin pathways presents a promising therapeutic avenue.
Abstract:
Coronary microvascular dysfunction (CMD) is being increasingly recognised as a significant contributor to myocardial ischaemia, particularly in patients without obstructive coronary artery disease. This review explores the anatomy and physiology of the coronary microcirculation, emphasising the role of endothelial dysfunction and endothelin-1 in CMD pathogenesis. We discuss diagnostic approaches, including invasive and non-invasive techniques, such as PET, cardiac MRI and intracoronary physiological testing. Current management strategies focus on risk factor modification and tailored pharmacotherapy, with emerging therapies targeting endothelin pathways. A comprehensive understanding of CMD is essential for improving diagnostic accuracy and developing effective treatments for patients presenting with ischaemic symptoms absent of angiographic evidence of coronary obstruction.
More Related Videos
07:16Dynamic Measurement and Imaging of Capillaries, Arterioles, and Pericytes in Mouse Heart
Published on: July 29, 2020
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:29Pathophysiology of Cardiac Performance
01:30Coronary Artery Disease I: Introduction
01:30Coronary Artery Disease III: Clinical Manifestations
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests